This guide supports health care providers, systems, and communities seeking to treat stimulant use disorders. It describes relevant research findings, examines best practices, identifies knowledge gaps and implementation challenges, and offers useful resources.
This advisory defines attention deficit hyperactivity disorder in adults, and explains interactions with substance use disorders.
This guide highlights the use of medication-assisted treatment (MAT) for opioid use disorder in drug courts. It reviews effective medications, including methadone, buprenorphine, and naltrexone. The guide also provides strategies to increase the use of MAT in drug court programs.
This report summarizes the clinical and cost effectiveness of crisis services. It also presents case studies of approaches states are using to coordinate, consolidate, and blend funding sources to provide robust crisis services.
This quick guide helps clinicians and other service providers address suicide and suicide prevention in patients living with substance use disorders. It covers risk factors and warning signs for suicide, core competencies, and information for administrators and clinical supervisors.
This advisory reviews diabetes and how it relates to mental illness, stress, and substance use disorders. It highlights ways to integrate diabetes care into behavioral health treatment, such as screening and intake, staff education, integrated care, and counseling support.
This brochure describes SAMHSA's free disaster technical assistance, training, and consultation efforts to help states, territories, tribes, and other disaster behavioral health providers plan for and respond effectively to mental health and substance use needs related to disaster events.
Millions of Americans have a substance use disorder. Find a treatment facility near you.
Free and confidential support for people in distress, 24/7.
Find treatment facilities confidentially and anonymously, 24/7.
Treatment referral and information, 24/7.